Thursday, March 27, 2014

Medical Gases and Equipment Market worth $14,953 Million by 2018

The “Medical Gases and Equipment Market by Gases (Oxygen, Medical Air, Nitrogen, Nitrous-oxide, Helium, Blood-gas Mixture, Nitrous Oxide-Oxygen Mixture), by Equipment (Cylinders, Manifolds, Regulators, Flowmeters) - Global Forecast to 2018” analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World.


The global market is estimated to be worth $10,416 million in 2013. The market is mainly driven by the growing aging population and the increasing home healthcare market. Advancements in technologies and devices coupled with the trend of continuous monitoring of diseases are also significantly compelling healthcare providers and payers to shift their focus from hospital care to home care settings.


The global medical gases and equipment market is segmented by product, application, and geography. By products, the market is broadly segmented into gases market and equipment market. The gases market is further segmented into medical pure gases and gas mixtures. The medical pure gases market covers gases like medical air, carbon dioxide, helium, nitrogen, nitrous oxide, and oxygen. Medical gas mixture is divided into blood gas mixtures, nitrous oxide-oxygen mixtures, carbon dioxide-oxygen mixtures, lung diffusion mixtures, laser gas mixtures, aerobic mixtures, and anaerobic mixtures. The equipment segment includes cylinders, vacuum systems, manifolds, regulators, suction regulators, flowmeters, hoses, outlets, and monitoring systems.

North America contributes the largest share to the global market, followed by Europe, Asia-Pacific, and Rest of the World. Developed geographies like North America and Europe are likely to grow at lower CAGRs as compared to the Asian market. The APAC region is expected to have the fastest market growth during the forecast period, largely driven by rapid growth in the developing healthcare industry across China and India.


The major players in the market include Linde Group (Germany), Praxair Inc. (U.S.), Air Products and Chemicals Inc. (U.S.), Air Liquide (France), Taiyo Nippon Sanso Corp. (Japan), Airgas Inc. (U.S.), Messer Group (Germany), Atlas Copco (Sweden), Matheson Tri Gas Inc. (U.S.), and SOL-SpA (Italy).


Wednesday, March 26, 2014

Dialysis Instrumentation Market worth $83.21 Billion by 2018

The report “Dialysis Market [(Hemodialysis - Machine, Dialyzer, Bloodlines, Concentrates, Services), (Peritoneal Dialysis - Cycler, Catheter, Dialysate, CCPD, CAPD, IPD), (End Users - Hospital, Independent Dialysis Center, Home Dialysis)] – Global Forecast to 2018”, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Asia-Pacific, Europe, and Rest of the World.


The global market is valued at $61.60 billion in 2013 and is expected to reach $83.20 billion by 2018, at a CAGR of 6.2% from 2013 to 2018.

In the report, the market has been segmented into hemodialysis and peritoneal products and services. The Hemodialysis products and services segment held the largest share of 85% in the global market, in 2012. Furthermore, the market has also been segmented on the basis of category (hemodialysis and peritoneal dialysis) and end-users (in-center dialysis and home dialysis). Inclination of patients towards home hemodialysis and nocturnal hemodialysis treatments exhibits a high growth potential for industry players in the near future.


North America holds the largest share of the global market. However, in the forthcoming years, developing regions such as Asia-Pacific (Japan, China, South Korea, and India), Latin America, and the Middle East are expected to form new revenue generating pockets for the market players. Economic developments, the presence of a large patient population, the growing number of dialysis centers, rising incidence and prevalence of diabetes and hypertension, and increasing government initiatives to develop/improve dialysis care are the key factors that drives the growth of the market in developing regions.


The market is majorly dominated by a few players such as Fresenius Medical Care AG & Co. KGaA (Germany), DaVita Healthcare Partners Inc. (U.S.), Gambro AB (Sweden), Baxter International Inc. (U.S.), and B. Braun Melsungen AG (Germany). Fresenius Medical Care holds the leading position in the market with a share of ~24% in 2013. Partnerships and collaborations are the key strategies adopted by market players to ensure their growth in the market. The introduction of the bundle reimbursement system has further lead to an increase in the number of collaborative partnerships among industry participants.



Tuesday, March 11, 2014

Disposable Medical Devices Sensors Market worth $6,212.7 Million by 2018


The “Disposable Medical Devices Sensors Market - By Type [Biosensor, Image sensor, Accelerometer] Monitoring[Smart Pill, Pulse Oximeter] Diagnostic[Capsule Endoscope, Blood Glucose Strip] Therapeutic[Insulin pump, Dialysis]- Global Forecast to 2018”, analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.


Early buyers will receive 10% customization in this report.

This report studies the global disposable devices sensors market over the forecast period of 2013-2018. The market is valued at an estimated $3,831.6 million in 2013 and is poised to grow at a CAGR of 10.1% from 2013 to 2018, to reach $6,212.7 million by 2018.

Request Sample:

Across the globe, sensor-based disposable devices are being increasingly used due to factors such as lower cost and their ability to reduce hospital acquired infections. A number of sensor-based disposable devices are available in the market. Furthermore, companies are engaged in developing new disposable devices sensors with advanced feature, which will help the market to grow further.

Enquiry before Buying:

The disposable medical devices sensors market is a highly fragmented market, as various segments have different leaders that depend on their expertise and product offerings. For instance, the capsule endoscopes market is dominated by Given Imaging (Israel), followed by Olympus Corporation (Japan). Various new entrants are entering the disposable devices sensors market, which increases the competition amongst players. The report provides an in-depth industry analysis (Porter’s five forces analysis) and opportunity analysis for established players as well as new entrants. The report also covers novel technologies that are expected to fuel the market in the near future. The product life cycle identifies products with the highest growth opportunities and the factors that propel and hinder their growth. The report also includes an analysis of benchmarking strategies adopted by leading players in the market for enhancing their market share and presence.

Wednesday, March 5, 2014

Sterilization Equipment Market worth $4.2 Billion by 2017

The “Sterilization Equipment Market [ETO Sterilization, E-Beam, Gamma, Steam, Vapor Hydrogen Peroxide (VHP), Hydrogen Gas Plasma, Ozone] (Medical Devices, Pharmaceutical, Healthcare, Food Applications), Equipments & Contract Services - Global Forecast To 2017”analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World (RoW).


Early buyers will receive 10% customization in this report.

The report focuses on various sterilization technologies like heat, chemical, radiation and filtration. The report also studies the sterilization services market, which includes healthcare solutions, hospital sterilization services, and applied sterilization technologies.

Free PDF Brochure:
http://www.marketsandmarkets.com/pdfdownload.asp?id=642

The sterilization applications market includes medical device, pharmaceuticals, life sciences, food, and cosmetics. The global sterilization market is valued at $3.1 billion in 2012 and is estimated to reach $4.2 billion by 2017 at a CAGR of 6.1%.

New technologies like E-beam and gamma are poised to have a strong market in the future due to their high product compatibility and low prices. These technologies have been beneficial for medical packaging, food irradiation, medical disposables, and microbiological equipment sterilization.

Enquiry before Buying:


Gene Expression Analysis Market worth $4.3 Billion by 2018

According to the new market research report, “Gene Expression Analysis Market by Technology (DNA Microarray, Real-Time PCR, Next Generation Sequencing), Consumables (DNA Chips, Reagents), Services (Gene Profiling, Bioinformatics, Data Analysis Software) & Applications - Global Forecast to 2018 ”, published by MarketsandMarkets, global gene expression analysis market estimated at $2.6 billion in 2013 and is expected to reach $4.3 billion by 2018, growing at a CAGR of 10.4% from 2013 to 2018.

Browse 72 market data tables and 20 figures spread through 227 pages and in-depth TOC on “Gene Expression Analysis Market”.
Early buyers will receive 10% customization on this report.

The global market was valued at $2.6 billion in 2013 and is expected to reach $4.3 billion by 2018, at a CAGR of 10.4%. Increasing number of cancer patients, growth in the number of funding activities, technological advancements, and increased interest in gene expression for research and discovery are the major factors driving the growth of this market. Moreover, various government bodies have extended their help in the form of investments, funds, and grants, which has further stimulated the growth of the market.


Gene expression analysis has emerged as a major advancement in the fields of drug discovery, diagnostics, and biomedical research. Since the completion of the Human Genome Project in 2003, numerous methods are being developed to improve the efficiency and effectiveness of gene expression profiling and sequencing. it is an important process, as it enables researchers to decipher the functions of genes. By sequencing genes, researchers can determine how diseases affect a cell. Genome-wide analysis can be used to accurately classify diseases. This has led to its increased use in various applications such as pharmacogenomics, diagnostics, toxicogenomics, and biomarkers.

This report broadly categorizes the global market into three segments, namely, instrumentation, consumables, and services. The large share of consumables is specifically attributed to the wide use of gene expression analysis techniques in cancer diagnostics. The increase in the number of genetic tests directly favors volume consumption of consumables. The gene expression services market is expected to grow at the highest CAGR of XX% from 2013 to 2018. This high growth can be attributed to the growing adoption of next-generation sequencing, advancements in bioinformatics tools, and the declining cost of sequencing.

Over the years, gene expression analysis has evolved significantly and is widely used for the diagnosis and treatment of various disorders like cancer, Alzheimer’s, and Parkinson’s, among others. In the past few years, the market has witnessed significant technological advancements, as companies have introduced newer sequencing and analysis platforms. This has aided in the diagnosis and treatment of diseases. This report covers the definition, description, and forecast of the global market in terms of instrumentation, consumables, services, and applications.


“The global market was valued at $2.6 billion in 2013 and is expected to reach $4.3 billion by 2018, at a CAGR of 10.4%. Increasing number of cancer patients, growth in the number of funding activities, technological advancements, and increased interest in gene expression for research and discovery are the major factors driving the growth of this market. Moreover, various government bodies have extended their help in the form of investments, funds, and grants, which has further stimulated the growth of the market.

Life Technologies (U.S.), QIAGEN N.V. (Netherlands), Illumina, Inc. (U.S.), Roche Diagnostics (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies (U.S.), Affymetrix, Inc. (U.S.), GE Healthcare (U.K.), Thermo Fisher Scientific (U.S.), PerkinElmer, Inc. (U.S.), Luminex Corporation (U.S.), and Oxford Gene Technology, Inc. (U.K.) are some of the prominent players in the global market.

Browse related reports:
Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] – Global Forecast to 2017


Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018


About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohans
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441